Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of ...

The pancreas contains Vitamin D receptors, which enable Vitamin D to affect insulin production, as well as the muscle and fat ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Congenital HI is a rare genetic condition that results in persistent hypoglycemia due to the overproduction of insulin. Ersodetug, a fully human monoclonal antibody, binds allosterically to insulin ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

A discovery in mice reveals why fasting enhances a type of breast cancer treatment — a hormone-signalling pathway and gene-expression changes have key roles. Stephen D. Hursting is in the Department ...

Excessive fructose intake from soft drinks is linked to liver damage and NAFLD. Lifestyle modifications are essential for ...

Rezolute said on Thursday its therapy aimed at controlling excessive insulin activity in patients with a rare genetic disorder did not show significant benefit in a late-stage trial.

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

Rezolute Inc.’s phase III Sunrize study of its only candidate, ersodetug, a fully human monoclonal antibody that binds to allosteric site on insulin receptors, missed its primary and secondary ...

Type 2 diabetes is a recognized risk factor for vertebral fractures, which can lead to long-term disability and increased ...

Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned ...